Rapid Dose Therapeutics Corp. (RDTCF)
- Previous Close
0.0080 - Open
0.0080 - Bid 0.0090 x --
- Ask 0.2000 x --
- Day's Range
0.0080 - 0.0080 - 52 Week Range
0.0021 - 0.3900 - Volume
10,000 - Avg. Volume
2,792 - Market Cap (intraday)
17.504M - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Oct 28, 2024 - Nov 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips containing active ingredients. In addition, the company sells health and wellness products, consisting of nutraceuticals and infused soaps; and white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing, as well as provides licensing and consulting services. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.
rapid-dose.comRecent News: RDTCF
View MorePerformance Overview: RDTCF
Trailing total returns as of 10/1/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RDTCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RDTCF
View MoreValuation Measures
Market Cap
17.51M
Enterprise Value
19.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.63
Price/Book (mrq)
--
Enterprise Value/Revenue
22.18
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-113.93%
Return on Equity (ttm)
--
Revenue (ttm)
1.18M
Net Income Avi to Common (ttm)
-5M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
113.06k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.84M
Company Insights: RDTCF
RDTCF does not have Company Insights